Amanda Seiz is an accomplished drug development leader with more than 25 years of experience spanning Phase 1 through Phase 4 clinical development. She has worked across a broad range of therapeutic areas, including oncology and rare diseases, and has held leadership roles within contract research organizations (CROs), emerging biotechnology companies, and large pharmaceutical organizations. Throughout her career, she has successfully led cross-functional and global teams, bringing together diverse expertise to advance clinical programs and support the development of innovative therapies.
